Completed PHASE1 INTERVENTIONAL 6-arm NCT00005022

Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

A Phase I/II Escalation Study of Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Lung Cancer

Interventions cisplatin etoposide radiation therapy

Updated 6 times since 2017 Last updated: Oct 31, 2013 Started: Feb 28, 1998 Primary completion: Oct 31, 2002 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Lung Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
Radiation Therapy Oncology Group

Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Albany, United States , Albuquerque, United States , Allentown, United States , Amarillo, United States , Anchorage, United States , Anderson, United States , Ann Arbor, United States , Annapolis, United States , Arlington Heights, United States and 193 more locations